Tech Company Financing Transactions
CryoFluor Therapeutics Funding Round
CryoFluor Therapeutics closed a Series B financing round on 4/12/2006. Investors included RCT BioVentures.
Transaction Overview
Company Name
Announced On
4/12/2006
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
RCT BioVentures (Thomas Shaffer)
Proceeds Purpose
The additional funds will allow the company to complete a feasibility clinical trial of its device to treat abnormal uterine bleeding.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
7545 Irvine Center Dr,
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Cryosurgery is the use of cold energy to kill tissue in the body without removing it. Typical cryosurgical devices are minimally invasive and consist of probes or needles that are placed into solid tissues under fluoroscopic or ultrasonic guidance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Martin
President
David Jackson
Browse more venture capital transactions:
Prev: 4/11/2006: GreenFuel Technologies venture capital transaction
Next: 4/12/2006: Authernative venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs